Raul E. Adrover
La Plata, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real-world experience from HCV-LALREAN cohort.
Journal: Journal of medical virology
Published: June 14, 2020
Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 03, 2019
Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 21, 2018
Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.
Journal: Journal of medical virology
Published: November 14, 2016
Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir.
Journal: Journal of viral hepatitis
Published: August 22, 2013
Validation of the number connection test for identifying patients with minimal hepatic encephalopathy.
Journal: Acta gastroenterologica Latinoamericana
Published: August 11, 2012
Breath-ammonia testing of healthy subjects and patients with cirrhosis.
Journal: Digestive diseases and sciences
Published: May 31, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026